在帕金森病中揭示分泌机制的缺陷
Francesca Filippini1, Thierry Galli2
1Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, USA; Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA.
The Journal of biological chemistry
|July 26, 2024
概括
缺陷的细胞分泌有助于神经退行性疾病,如帕金森氏症,通过损害神经元功能和促进有毒蛋白质的积累. 结合分泌缺陷和蛋白质积累,导致疾病的发病和进展.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 细胞生物学 细胞生物学
- 神经退行性疾病的发病因子
背景情况:
- 神经退行性疾病涉及渐进的神经元损失和功能障碍.
- 研究传统上侧重于遗传/表观遗传因素.
- 新出现的证据表明,疾病发病和非细胞自主机制中的分泌缺陷.
研究的目的:
- 审查缺陷分泌在神经退行性疾病发病过程中的作用.
- 为了强调分泌缺陷在帕金森病中的影响.
- 为疾病发病和进展提出一个多因素模型.
主要方法:
- 文献综述侧重于神经退行症中的分泌机制.
- 对缺陷分泌在帕金森病中的作用的分析.
- 综合证据,将蛋白质聚合与分泌功能障碍联系起来.
主要成果:
- 缺陷分泌会破坏细胞间通信和神经元的生存.
- 失效的分泌有助于蛋白质错误折叠,聚合和神经毒性.
- 帕金森病的特定作用包括蛋白质聚合,突触功能障碍和神经炎症.
结论:
- 缺陷分泌是神经退行性疾病发病的一个关键因素.
- 蛋白质积累和分泌缺陷的组合驱动了帕金森病的发病和进展.
- 这突出了非细胞自主机制和潜在的治疗点.
相关概念视频
Parkinson's Disease: Overview
510
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
510
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Overview of Secretory Vesicles
8.5K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.5K


